Elder Pharmaceuticals plans to recruit 1,000 sales and marketing professionals within two months, mainly to sell drugs in untapped rural markets.
“There has been a revival in demand across pharmaceutical segments, but the real growth story lies in the rural and semi-urban markets, which we expect to grow at about 15 per cent annually from the current level,” said Alok Saxena, director at Elder Pharmaceuticals.
Elder Pharma employs about 3,300 people in India, with about 2,700 professionals in marketing and sales. This recruitment will help Elder Pharma to have one of the largest drug sales force in India, like market leaders such as Cipla, Ranbaxy, Piramal Healthcare and Lupin.
He said the Rs 600-crore company would launch nine-12 new products in this financial year in India. He said in addition to doctors, Elder Pharma had plans to reach out to physicians, specialists and chemists, hospitals, nursing homes and private healthcare institutions in rural and semi-urban areas in a major way.
Elvista, Elder Pharma’s rural division, already has presence in the rural and semi urban markets of Uttar Pradesh, Maharashtra, Andhra, Bengal and Bihar and certain areas in South India.
By December 2012, Elvista plans to reach 1,500 villages, with population of below 40,000, 300 villages with population of 40,000 to 1,00,000 and over 75 peripheral villages and towns around MMR (Mumbai Metropolitan region). Elder sells over 350 products with focus on generics, women’s healthcare, pain management lifestyle diseases.
Elder Pharma, according to drug sales tracking agency ORG IMS, was the fastest growing pharma company in India during 2009 calendar year, said Saxena.
India is likely to become one of the top 10 global pharmaceuticals markets in terms of sales by 2020, with the total value reaching about $50 billion, according to a recent report by PricewaterhouseCoopers (PwC).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
